Back to Search
Start Over
Reply to: "Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed".
- Source :
-
Hepatology international [Hepatol Int] 2024 Oct; Vol. 18 (5), pp. 1589-1590. Date of Electronic Publication: 2024 Jul 08. - Publication Year :
- 2024
- Subjects :
- Humans
Prognosis
Immune Checkpoint Inhibitors therapeutic use
Carcinoma, Hepatocellular therapy
Carcinoma, Hepatocellular drug therapy
Liver Neoplasms therapy
Liver Neoplasms drug therapy
Liver Neoplasms pathology
Phenylurea Compounds therapeutic use
Quinolines therapeutic use
Chemoembolization, Therapeutic methods
Subjects
Details
- Language :
- English
- ISSN :
- 1936-0541
- Volume :
- 18
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Hepatology international
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38976226
- Full Text :
- https://doi.org/10.1007/s12072-024-10682-6